Sunway Says Malaysia Medical Tourism Stays Shielded

Malaysia’s medical tourism trade is holding up against the instability in the Middle East, Sinar Daily reported, because its inbound patients come mostly from elsewhere. Chelsea Cheng, chief financial officer of Sunway Healthcare Holdings Bhd, said the group draws its foreign patients mainly from ASEAN and China, with most of the volume coming from neighbouring countries in Southeast Asia. Speaking at a press conference after the company’s listing ceremony in Kuala Lumpur, Cheng said the sector did not lean heavily on European tourists and was “pretty much shielded” from the current turmoil.

A source market that sits away from the conflict

Cheng framed the position as a matter of where the patients come from, Sinar Daily reported. With the United States-Iran conflict weighing on travel from the Middle East and Europe, a patient base concentrated in Southeast Asia and China leaves the group’s medical tourism outlook largely untouched, and she said the company was confident about that outlook for the year.

This is the concentration argument running in reverse. In India, hospitals built on Gulf and West Asian patients are absorbing the shock of closed airspace, because a region that supplies the patients also supplies the risk. Malaysia’s inbound base sits away from the conflict, so the same volatility barely reaches the ward. Concentration is not safe or dangerous in itself; it is a bet on a particular set of source markets staying calm, and Malaysia’s bet is pointed at its neighbours rather than at the Gulf.

A currency tailwind, and a caveat

Datuk Lau Beng Long, president of Sunway Healthcare Group, said he expected more Middle Eastern patients to choose Malaysia, and pointed to Dubai as a source market to court, Sinar Daily reported. Lau suggested patients who once sought treatment within their own region might now look to Malaysia and the wider Asian continent for care until stability returns.

A strong ringgit is helping. Lau said the currency’s strength against the Singapore dollar had aided the group, and reported “a notable shift in medical tourism from Indonesia to Malaysia,” Sinar Daily reported. The ringgit firmed against the Singapore dollar to 3.0621/0806 from 3.0635/0673 the day before. That is a real advantage, but a currency move is a tailwind rather than a built position, and it can reverse as quickly as it arrived while adding no beds. The durable part of Malaysia’s insulation is the diversified source base, not the exchange rate on any given day.

A large listing behind the confidence

The comments came as Sunway Healthcare made its market debut. Its shares listed on the Main Market of Bursa Malaysia on Wednesday and opened at RM1.70, a 25 sen premium over the initial public offering price of RM1.45, on trading volume of 38.37 million shares, Sinar Daily reported. The company said the offering raised RM3.3 billion across its base offering and an over-allotment option, which it described as Malaysia’s largest listing in nine years and the second largest in ASEAN’s healthcare sector to date.

A listing is a capital event, not a measure of patient capacity. The RM3.3 billion shows what investors will pay for the story, not how many foreign patients passed through a hospital ward last quarter. Tan Sri Dr Jefrey Cheah, founder and chairman of Sunway Group, said the group aspired to build a Malaysian healthcare institution able to rival the finest medical centres in the world, Sinar Daily reported. That is the management view, delivered on listing day, and it should be read as the company talking its own book alongside the figures.

What to watch

Malaysia’s confidence rests on a source base that has so far kept the sector steady, and the wider read is consistent. The country’s finance minister has called medical tourism demand strong, even as the RM33 billion the sector reports has reopened a debate about specialists. The stance stands in contrast to the Gulf patient flows that fell across the rest of Asia.

The tests are dated and checkable. Whether the group’s ASEAN and China base holds its patient numbers through the year is the first thing to watch. Whether the promised shift of Middle Eastern patients from Dubai to Malaysia shows up in arrivals, rather than forecasts, is the second. Whether the ringgit advantage survives the next turn in the currency market is the third, and it is the one Malaysia controls least.